RIDA®GENE Lac Intol
Intended use:For in-vitro diagnostic use. The RIDA®GENE Lac Intol test, which is performed on the LightCycler® 480 II, is a multiplex real-time PCR for the qualitative detection and [...]
Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
RIDA®GENE Pediatric Viral Panel
Intended use:For in vitro diagnostic use. The RIDA®GENE Pediatric Viral Panel test, performed on the LightCycler® 480 II real-time PCR instrument, is a multiplex real-time RT-PCR for the direct [...]
More efficient and flexible: RIDA®GENE real-time PCR kits in the new format
The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.
And again: Cold – Cough – Fever
Publications
Legionella and mycoplasma pneumoniae: New RIDA®GENE products for detection of atypical CAP bacteria
Community-acquired pneumonia (CAP) is the most common fatal infectious disease in western countries. Bacteria are the most common pathogens causing CAP, where one differentiates between typical [...]
Interview: Tuberculosis Diagnostics at R-Biopharm
“Early and consistent tuberculosis detection to break infection chains and eliminate the disease worldwide” R-Biopharm has launched a new generation of diagnostics for the global [...]
32nd Annual Meeting of the Society for Virology
ESCV 2022
R-Biopharm announces quality products distribution agreement with Microbix
Mississauga, Canada and Darmstadt, Germany, 15th May 2020 – R-Biopharm AG and Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator, announces the appointment of R-Biopharm [...]